A Perspective on the Primary Care of Patients With Behavior, Mood, and Thought Disturbances: Clinical Applications of Olanzapine.

Prim Care Companion J Clin Psychiatry

Eli Lilly and Company, Indianapolis, Ind.; and TLC Care Professional Corporation, Indianapolis, Ind.

Published: October 2001

Primary care practitioners are in an ideal position to initiate treatment for patients with behavior, mood, and thought disturbances. It is believed that early identification and treatment of these symptomatic features of primary or secondary central nervous system disorders may significantly reduce morbidity and benefit the patient, his/her family, and involved caregivers, including the primary care physician. A broad list of central nervous system-active medications are utilized by family physicians to treat patients who exhibit symptoms of agitation, altered mood, and disordered thought. Some medications have demonstrated superiority over placebo or active medicines in reported clinical trials. This article is a brief overview of the safety and efficacy from reported studies of the use of medications frequently used to treat symptoms related to behavior, mood, and thought disturbances, with a specific focus on the clinical applicability of olanzapine.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC181215PMC
http://dx.doi.org/10.4088/pcc.v03n0502DOI Listing

Publication Analysis

Top Keywords

primary care
12
behavior mood
12
mood thought
12
thought disturbances
12
patients behavior
8
central nervous
8
perspective primary
4
care patients
4
mood
4
thought
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!